A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty
Status:
Not yet recruiting
Trial end date:
2022-06-10
Target enrollment:
Participant gender:
Summary
A single preoperative dose of tranexamic acid (TXA) reduces blood loss and red blood cell
transfusion in primary hip arthroplasty. Numerous regimens have been tested, ranging from
10mg/kg up to 3g. However the optimal dose to administer is unknown.